Abstract. This report describes a trans-species rescue of defective MSV genome with helper leukemia virus derived from cats. This rescue was achieved by in vitro co-cultivation of hamster tumor cells with feline embryo cells in the presence of helper feline leukemia virus (FeLV), or by inoculation of tumor cells into FeLV-infected newborn cats.
Erratum. In the article "Trans-Species Rescue of Defective Genomes of Murine Sarcoma Virus from Hamster Tumor Cells with Helper Feline Leukemia Virus," by Padman S. Sarma, T. Log, and Robert J. Huebner, which appeared in the January 1970 issue of these PROCEEDINGS (vol. 65, pp. 81-87), the following sentence in the second paragraph of the introduction (page 81) should read: "However, the presence in such cells of the sarcoma virus genome can be demonstrated by one or more procedures such as rescue of sarcoma virus by direct superinfection of transformed cells with helper virus,'-3' 11,12 rescue of sarcoma virus genome by in vitro or in vivo association of tumor cells with homologous host cells in the presence of helper virus,7-W0 detection of the release of labeled virus,'3'14detection of focus-forming virus with a very restricted host-range," ' 15-18 and by immunological identification of the presence of virus-specific antigens.7 1820 In reference 33, for (Based/New York: Karger, in press) read (Basel/New York: Karger, in press).
Erratum. In the article "Topological Relationship of Prophage X to the Bacterial Chromosome in Lysogenic Cells," by David Freifelder and Matthew Meselson, which appeared in the January 1970 issue of these PROCEEDINGS (vol. 65, pp. 200-205), the following corrections should be made: In the second paragraph on page 203, on the fifth line, for 1: 1.45, read 1: 1.47; on the eighth line, for 1.45, read 1.32.
Most strains of avian and murine sarcoma viruses are defective and are unable to produce their viral envelopes without assistance from closely related nondefective helper leukemia viruses.'-4 Such defective sarcoma viruses are generally found in association with an excess of helper virus.1-5 The resultant co-infection of homologous host cells with sarcoma and leukemia viruses permits the replication of the infectious progeny sarcoma virus which derives its viral envelope from the helper virus.1-4 Thus, the sarcoma virus has the antigenic and host-range characteristics of the helper virus. [1] [2] [3] [4] Avian cells infected under conditions which only permit solitary infection with the defective sarcoma virus, 1 2, 6 as well as heterologous mammalian cells transformed in vivo or in vitro by low or high multiplicity of avian or murine sarcoma viruses,7-10 generally fail to show evidence of the release of infectious progeny sarcoma or leukemia viruses when usual tests for infectious virus are performed using cultures of the homologous host species. However, the presence in such cells of the sarcoma virus genome can be demonstrated by one or more procedures such as rescue of sarcoma virus by direct superinfection of transformed cells with helper virus, -3 11-13 rescue of sarcoma virus genome by in vitro or in vivo association of tumor cells in the presence of helper virus,7-10 detection of the release of labeled virus,13 14 detection of focus-forming virus with a very restricted host-81 range,11 [15] [16] [17] [18] and by immunological identification of the presence of virus-specific antigens.7' [18] [19] [20] Feline leukemia (lymphosarcoma) is now known to be caused by a C-type RNA virus. 24 The hamster tumor cells contained the MSV genome, but no detectable murine leukemia virus group complement-fixation antigens or infectious murine leukemia virus or MSV capable of replication in MEF cultures.8. 14, 18, 82 Secondary cultures of feline embryo fibroblasts (FEF) and NIH Swiss mouse embryo fibroblast (MEF) were used. The growth medium for these cultures and hamster tumor cells consisted of Eagle's minimum essential medium supplemented with 2 mM -glutamine, 5-10% unheated fetal bovine serum, 5% tryptose phosphate broth and antibiotics (penicillin, 250 unit/ml; streptomycin, 250,ug/ml; and fungizone, 25 ,ug/ml). In vitro MSV genome rescue studies: Hamster tumor cells were grown in mixed culture with secondary cultures of FEF similar to procedures already described7. 8; 5 X 105 FEF and 5 X 10' hamster tumor cells were planted in 5 ml of culture medium in each 60-mm disposable culture dish. Half the number of cultures in each group containing two to four mixed cultures and equal numbers of control FEF cultures and control hamster tumor cultures were immediately infected in suspension with 106 infectious units of FeLV. These cultures and parallel uninfected control cultures were maintained by medium replacements at 3 day intervals and by cell transfer at weekly intervals.
Culture supernatants of FeLV-infected and parallel uninoculated cultures were collected on the 4th, 8th, 12th, and 16th day after virus infection and clarified by filtration through Swinney filters fitted with 0.45 M Millipore filters. The supernatants were tested for focus-forming virus by inoculation into secondary MEF and FEF cultures.
These cultures and control MEF and FEF cultures were maintained and observed for foci. 4 The culture media were replaced at 3-day intervals and the cells were serially transferred at approximately weekly intervals. The experiment was concluded 30 days after inoculation of culture supernatants.
In vivo genome rescue8: Kirsten MSV hamster tumor tissue culture cells were removed from monolayer bottle cultures by trypsinization. Three to five newborn kittens from one litter were inoculated intramuscularly in the right thigh with 0.6 ml of the virus-hamster tumor cell mixture containing 106 infectious units of FeLV and 2 X 106 hamster tumor cells. The animals were left with the mother and observed for tumor development.
When tumors reached sizes of 20 to 30 mm within 12 to 15 days, the animal was killed. The tumors, weighing 7-8 gm, were removed and tested for focus-forming virus by inoculation of clarified, cell-free 10% tumor extracts in MEF and FEF cultures.
Virus stocks of recovered focus-forming viruses: The focus-forming viruses rescued in these experiments were prepared into virus stocks as clarified culture supernatants of infected FEF cultures that showed confluent cell transformation within 5 to 8 days after inoculation of virus. In some experiments, cells and fluids were also collected, quick frozen, and thawed once and clarified. Virus stocks stored at -70oC generally gave focus titer in FEF of 2 X 103 to 104 per ml.
Assay of focus-forming virus: The focus-forming viruses recovered in these experiments were assayed in secondary cultures of FEF planted in 60-mm Petri dishes. The cultures were infected in suspension. Culture media were replaced on the 3rd day with media containing reduced concentration of serum (5%). Foci of transformed cells were counted 6 days after virus inoculation with a Leitz inverted microscope.
Oncogenicity in newborn kittens: One litter of three newborn kittens was inoculated intramuscularly with 0.5 ml each of Moloney MSV-feline leukemia pseudotype virus. The animals were left with their mother and observed for tumor development. Animals which died were autopsied and tumors were collected for histopathological examination. s Test of virus stocks for defectiveness: Stocks of MSV-feline leukemia pseudotype viruses were prepared by harvesting FEF culture fluids at 3 and 7 days after virus inoculation. These preparations were clarified by filtration and assayed in FEF cultures in 5-fold dilution steps. Parallel sets of inoculated FEF cultures were also simultaneously infected with 106 infectious units of FeLV to determine helper activity. The foci of transformed cells were counted after 6 days.
Viral interference test: The ability of FeLV to interfere with focus formation of the rescued MSV-feline leukemia pseudotype viruses was tested by a procedure similar to that described for murine leukemia viruses.-, FEF infected with a high multiplicity of FeLV were maintained for 20 days to establish virus infection in the majority of the cells. The cells were then transferred to 60-mm plastic dish cultures at a concentration of 5 X 105 cells in 5 ml of growth medium. Cultures were immediately separately infected with 103 focus-forming units of the MSV-feline leukemia pseudotype viruses. The sensitivity of FeLV-infected and control cultures to vesicular stomatitis virus was also determined by plaque assay.
Virus neutralization test: Antisera prepared in rabbits33 against FeLV and in rats against MSV were tested for their capacity to neutralize the focus-forming viruses recovered in these experiments. FeLV antiserum was prepared by hyperimmunization of rabbits with intact FeLV. A pool of sera of MSV tumor-bearing rats containing a high titer of murine leukemia group-specific complement-fixing antibodies and virus neutralizing antibodies to the murine leukemia viruses of the FMR subgroup was kindly provided by Dr. Janet Hartley. Sera were heated at 560C for 30 min before use.
Equal parts of sera diluted 1: 5 and virus dilutions were mixed and incubated at room temperature for 30 min and at 40C for the following 30 min. The presence of focus-forming virus in the virus-serum mixtures was tested by inoculation into FEF cultures. Cell-free culture fluids of FEF cultures which showed confluent cell transformation effects induced foci in FEF but not in MEF cultures. In addition, foci of morphologically altered cells were observed in certain human fibroblast cultures inoculated with these preparations. 37 No visible effects were observed in secondary embryo fibroblast cultures of rat, hamster, and mouse species. The focusforming virus could be serially propagated indefinitely in FEF cultures. Cellfree culture fluid preparations contained 2 X 103 to 104 focus-forming units per milliliter. For identification purposes, the following provisional virus designations were given using the strain of MSV followed by FeLV within parentheses to signify isolation with FeLV helper: Moloney MSV(FeLV), Kirsten MSV(FeLV), and Harvey MSV(FeLV).
In vivo genome rescue studies: Tumors measuring 20 to 30 mm were observed in all inoculated newborn kittens within 15 39 Studies are in progress to determine if the complement-fixation reaction observed is due to a component of the group-specific antigens of the viruses of the murine leukemia-sarcoma group.
These experiments indicate that different strains of MSV are identical in their biological behavior in being able to furnish genomes for encapsidation with FeLV envelope. The rescue studies have also been recently confirmed with additional field isolates of FeLV.
Fischinger and O'Connor28 provided evidence to indicate that focus-forming viruses similar to those described here can be recovered by infecting cat cells with FeLV-defective MSV interviral pellets. The virus isolated induced foci and propagated in cell cultures of cat,28 dog and human species40 but not in mouse species, and appeared to have the viral envelope of FeLV.
We have found that murine and avian leukemia and sarcoma viruses do not share common antigens and do not interact to form pseudotype viruses by the viral genome rescue techniques.4' Whether they will do so by physical techniques28 remains to be determined.
The interaction between MSV and FeLV and their immunological relatedness27 indicates that these viruses may have a common origin. It is conceivable that biologically related, but as yet undetected RNA viruses of the C-type may be involved etiologically in cancers of other species including man.
